Substance

ID:73397

Names and Identifiers
IUPAC name
(1R,3S,8E,12R,14E,16E,18E,20E,24S,25R,26S)-22-{[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0^{5,7}]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
IUPAC Traditional name
(1R,3S,8E,12R,14E,16E,18E,20E,24S,25R,26S)-22-{[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0^{5,7}]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
Synonyms
PimaricinNatacynNatamycin(Pimaricin)
Registration numbers
CAS Number
Properties
Product Information
Salt Data
Free Base
Safety Information
Storage Condition
-20°C
Molecule Details
Research Area: Infection
Biological Activity:
Natamycin(Pimaricin) is a naturally occurring antifungal agent produced during fermentation by the bacterium Streptomyces natalensis. Most Molds have an MIC(Minimum inhibitory concentration) of <10ppm. Natamycin(Pimaricin) is classified as a macrolide polyene antifungal. As a drug, it is used to treat fungal keratitis. It is especially effective against Aspergillus and Fusarium corneal infections. [1]
Molecular Spectra
No Data Available
Click here to submit data
References
•  http://en.wikipedia.org/wiki/Natamycin